Table 4.
Cost per patient in US dollars (USD)
| Cost per patient by outcome category | USD cost (95% Confidence Interval) | ||||
|---|---|---|---|---|---|
| N | Standard | N | Rapid | Difference | |
|
| |||||
| All patients | 108 | 319.08 (278.82 – 359.33) | 105 | 451.19 (403.74 – 498.65) | 132.12 (83.20 – 181.03) |
| Viral suppression by 10 months (primary outcome) | 46 | 487.45 (465.95 – 508.95) | 67 | 505.42 (481.17 – 529.67) | 17.97 (−16.69 – 52.62) |
| Unsuppressed or not reported | 17 | 431.61 (375.70 – 487.53) | 17 | 478.94 (398.56 – 559.32) | 47.33 (−54.43 – 149.09) |
| Lost to follow up | 45 | 104.45 (74.96 – 133.93) | 21 | 255.73 (207.15 – 304.31) | 151.28 (95.82 – 206.74) |
|
| |||||
| Cost breakdown for patients achieving primary outcome | USD cost (%) | ||||
| Standard | Rapid | ||||
|
|
|||||
| Drugs | 86.66 (18%) | 93.56 (19%) | |||
| Lab tests | 44.43 (9%) | 116.95 (23%) | |||
| Clinical staff visit cost | 152.43 (31%) | 151.81 (30%) | |||
| Fixed costs (buildings, equipment, management, admin) | 203.92 (42%) | 143.09 (28%) | |||
| Total per patient achieving primary outcome | 487.44 (100%) | 505.42 (100%) | |||